Observational studyThe journal of headache and pain2023

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Albert Muñoz-Vendrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.